Make Smarter Decisions in Drug Design
We’re advancing small molecule drug discovery, with proprietary tools and technology, expertise, and an all-in approach to collaboration that sets you up for success. Tackling challenges, sharing insights, and driving progress together is how we aim to achieve success in every project.
Scale Up
Expand your capacity and capabilities
Services

Tailored Services for Your Research Objectives
MFI delivers solutions and support to meet your specific projects needs, including expanded CADD (computer-aided drug design) capacity, research consultation, and novel software applications.
Software That Works Like a Partner
MFI’s proprietary tools and technology are designed to deliver the confidence you need in hit discovery, hit-to lead, and lead optimization.
Products


MFI has been delivering CADD through a highly collaborative research-as-a-service model. Integrating what we’ve learned into new and evolving software tools, we’re becoming a go-to partner in small molecule drug design.

What’s New
A growth milestone; letter from the CEO
Dear Team, Today, we’re hitting an exciting milestone in our journey—welcoming our tenth team member! This moment marks not just growth in numbers but a significant step in our evolution as a company. Reflecting on our journey, I’m so proud of how...
2024 Q1 Patch Update
IMPACTS: Addition of four new CYP isoforms for SoM predictions (2A6, 2B6, 2C8, and 2E1). Use of SASA correction factor to improve activation energy assignment. SELECT: Use of Tversky index in addition to Tanimoto coefficient for seach similarity....
Feature in The Globe and Mail
We were featured in The Globe and Mail article titled “In the quest for new medicines, developers seek to make AI their divining rod”.
A Select Few of Our Clients




A Select Few of Our Partners




What Our Clients and Partners Say